Vascular adhesion molecules and modulation of their function

Details for Australian Patent Application No. 2005202246 (hide)

Owner Laboratoires Serono S.A.

Inventors Aurrand-Lions, Michel; Imhof, Beat Albert

Agent Shelston IP

Pub. Number AU-B-2005202246

Parent 782139

Filing date 24 May 2005

Wipo publication date 16 June 2005

Acceptance publication date 20 December 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

9 June 2005 Complete Application Filed

16 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202246

6 April 2006 Assignment before Grant

  RMF Dictagene S.A. The application has been assigned to Laboratoires Serono S.A.

20 December 2007 Application Accepted

  Published as AU-B-2005202246

24 January 2008 Corrigenda

  Applications Accepted - Name Index Under the name Laboratoires Serono S.A., Application No. 2005202246, under INID (71), correct the name to read Laboratoires Serono S.A. Coinsins

17 April 2008 Standard Patent Sealed

30 April 2009 Alteration of Name

  The name of the patentee has been altered to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202247-Rapid comestible fluid dispensing apparatus and method

2005202245-Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists